Suresh B. Pillai, Ph.D.
Suresh B. Pillai prepares and prosecutes patent applications, conducts legal research, and provides technological advice in support of validity, infringement and patentability analyses, patent application preparation and prosecution, and litigation matters in the biotechnology field. Prior to joining MBHB, Dr. Pillai was a Genomics Field Applications Specialist at Bio-Rad Laboratories.
education
J.D., DePaul University College of Law, Cum Laude
Post-Doctoral Fellowship, Northwestern University
- Research: The reproductive pathogenesis of mice lacking classical estrogen receptor signaling mechanisms.
Ph.D., University of Maryland, Physiology
Dissertation: The uterotrophic effects of relaxin: activation of ligand-independent estrogen receptor-mediated transcription.
M.S., University of Maryland, Physiology
B.A., University of Virginia, Chemistry
bar admissions
Illinois
U.S. District Court for the Northern District of Illinois
U.S. Patent & Trademark Office
publications
Suresh B. Pillai, Mr. Soderbergh Goes to Washington: How Congress and the Clean Flicks Court Created Moral Rights for Filmmakers, 17 DePaul-LCA J. Art & Ent. L. & Pol'y, 339 (2007).
Glidewell-Kinney C, Weiss J, Lee EJ, Pillai S, Ishikawa T, Ariazi E, and Jameson JL. 2005. ERE-independent ERalpha target genes differentially expressed in human breast tumors. Molecular and Cellular Endocrinology 254: 53-59.
Pillai SB, Jones JM, and Koos RD. 2002. Treatment of Rats With Either Estradiol or Relaxin (an Estrogen Receptor Activator) Inhibits Uterine Expression of Estrogen Receptor-beta 1 and 2 (ER-?1 and ER-?2). Biology of Reproduction 67: 1919-1926.
Rockwell LC, Pillai SB, Olson CE, and Koos RD. 2002. Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biology of Reproduction 67: 1804-1810.
Pillai SB, Sherwood OD, and Koos RD. 2001. Relaxin Up-regulates Rat Uterine Vascular Endothelial Growth Factor (VEGF) mRNA In Vivo. Relaxin 2000: Proceedings of the 3rd International Conference on Relaxin and Related Peptides, p. 109-113.
Koos RD and Pillai SB. 2001. Intersection of the Relaxin and Estrogen Signaling Pathways in the Uterus. Proceedings of the 3rd International Conference on Relaxin and Related Peptides, p. 101-107.
Pillai SB, Rockwell LC, Sherwood OD, and Koos RD. 1999. Relaxin Stimulates Uterine Edema via Activation of Estrogen Receptors: Blockade of its Effects using ICI 182, 780, a Specific Estrogen Receptor Antagonist. Endocrinology 140:5: 2426-2429.